NUMELVI (Atinvicitinib Tablets) for Dogs 21.6mg, Single Count - Tablets

Description

NUMELVI® (Atinvicitinib Tablets) for Dogs is a prescription medication indicated for the control of pruritus (itching) associated with allergic dermatitis and for the management of atopic dermatitis in dogs. As a targeted Janus kinase (JAK) inhibitor, NUMELVI helps interrupt itch and inflammation pathways, providing relief from allergic skin conditions while supporting improved comfort and quality of life. Available in multiple tablet strengths to allow accurate dosing based on body weight and veterinary recommendations.

Key Benefits

• Helps control itching associated with allergic dermatitis in dogs.
• Manages clinical signs of canine atopic dermatitis.
• Targets itch and inflammation pathways through JAK inhibition.
• Available in multiple strengths for individualized dosing.
• Convenient oral tablet formulation for daily administration.

Ingredients

Active Ingredient:
Atinvicitinib

Available Strengths:
4.8 mg, 7.2 mg, 21.6 mg, and 31.6 mg tablets

Inactive Ingredients:
Proprietary tablet excipients and flavoring agents. Refer to product packaging for a complete list of inactive ingredients.

Directions for Use

Use only as directed by your veterinarian. Administer orally according to your dog's prescribed dosage and treatment schedule. Tablets may be given with or without food unless otherwise directed by your veterinarian.

Warnings

• Federal law restricts this drug to use by or on the order of a licensed veterinarian.
• For use in dogs only.
• Keep out of reach of children and other animals.
• Not intended for use in dogs with serious infections unless directed by a veterinarian.
• Routine veterinary monitoring may be recommended during treatment.
• Discuss concurrent medications and vaccinations with your veterinarian before use.

Storage

Store at controlled room temperature. Keep the container tightly closed and protect from excessive moisture and heat.